bioRxiv ScienceSearch

bioRxiv · 10.1101/436865

Zika Virus Subverts Stress Granules to Promote and Restrict Viral Gene Expression

Abstract

Flaviviruses limit the cell stress response by preventing the formation of stress granules and utilize different proteins involved in the stress granule pathway to modulate viral gene expression. In this study, we investigated the formation of stress granules during Zika virus (ZIKV) infection and the role stress granule proteins play during the viral life cycle. Using immunofluorescence and confocal microscopy, we determined that ZIKV disrupted the formation of arsenite-induced stress granules and changed the subcellular distribution, but not the abundance or integrity of stress granule proteins. To investigate the role of different stress granule proteins in ZIKV infection we used target-specific siRNAs to deplete six proteins, namely Ataxin2, G3BP1, HuR, TIA-1, TIAR and YB-1. Depletion of TIA-1 and TIAR affected ZIKV protein and RNA levels, but viral titers did not change. Conversely, depletion of Ataxin2 and YB-1 decreased virion production despite having only a small effect on ZIKV protein and expression. Notably, however, depletion of G3BP1 and HuR decreased and increased ZIKV gene expression and virion production, respectively. Using an MR766 Gaussia luciferase reporter genome together with knockdown and overexpression assays, G3BP1 and HuR were found to modulate ZIKV replication. These data indicate that ZIKV disrupts the formation of stress granules by sequestering stress granule proteins required for replication, which is where G3BP1 functions to promote ZIKV infection, while HuR exhibits an antiviral effect. The consequence of ZIKV re-localizing and subverting select stress granule proteins might have broader consequences on cellular RNA homeostasis contributing to cellular gene dysregulation and ZIKV pathogenesis.\n\nImportanceIn response to viral infection, cellular translation is stalled, and translation initiation complexes, cellular mRNAs, and RNA binding proteins aggregate in stress granules. Because the assembly of stress granules antagonize translation of viral proteins, which is a critical step for single-stranded positive-sense RNA viruses to replicate the viral genome, many viruses have developed strategies to inhibit stress granule formation. In this study, we observed that Zika virus restricts the formation of stress granules likely by re-localizing specific stress granule proteins during infection. We also determined that specific stress granule proteins function to facilitate and limit Zika virus replication. This interaction of Zika virus with stress granule proteins is interesting, as many stress granule proteins are also known to function in neuronal granules, which are critical in neural development and function. Moreover, dysregulation of different stress granule proteins in neurons has been shown to play a role in the progression of neurodegenerative diseases. The likely consequences of Zika virus modulating stress granule assembly and subverting specific stress granule proteins are alterations to cellular mRNA transcription, splicing, RNA stability, and translation. Such changes in cellular ribostasis could have profound effects on neural development and contribute to the devastating developmental and neurological anomalies observed following intrauterine Zika virus infection. Our study provides new insights into virus-host interactions and the identification of the stress granule proteins that may contribute to the unusual pathogenesis associated with this reemerging arbovirus.

Source connections

Explore related subjects

Keep this discovery

BibTeXRIS

Bonenfant, G., Williams, N., Netzband, R., Schwarz, M., Evans, M. J., Pager, C. T.. 2018-10-05. Zika Virus Subverts Stress Granules to Promote and Restrict Viral Gene Expression. https://doi.org/10.1101/436865

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology